Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen

Institut für Pathologie

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Mayer, Philipp; Hausen, Anne; Steinle, Verena et al.

The radiomorphological appearance of the invasive margin in pancreatic cancer is associated with tumor budding

LANGENBECKS ARCHIVES OF SURGERY. Bd. 409. H. 1. 2024


Kaufmann, Justus; Haist, Maximilian; Kur, Ivan-Maximiliano et al.

Tumor-stroma contact ratio- a novel predictive factor for tumor response to chemoradiotherapy in locally advanced oropharyngeal cancer

TRANSLATIONAL ONCOLOGY. Bd. 46. 2024


Armandi, Angelo; Liguori, Antonio; Merizian, Talal et al.

Accuracy of 100 Hz transient elastography-based spleen stiffness for the identification of advanced fibrosis in biopsy-proven nonalcoholic fatty liver disease

JOURNAL OF HEPATOLOGY. Bd. 78. 2023 S. S654-S655



Cifci, Didem; Veldhuizen, Gregory P.; Foersch, Sebastian et al.

AI in Computational Pathology of Cancer: Improving DiagnosticWorkflows and Clinical Outcomes?

ANNUAL REVIEW OF CANCER BIOLOGY. Bd. 7. 2023 S. 57-71


Schmid, Christian David; Olsavszky, Victor; Reinhart, Manuel et al.

ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions in hereditary hemorrhagic telangiectasia of the liver

HEPATOLOGY. Bd. 77. H. 4. 2023 S. 1211-1227


Roesler, Wiebke; Altenbuchinger, Michael; Baessler, Bettina et al.

An overview and a roadmap for artificial intelligence in hematology and oncology

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023


Staubitz, Julia I.; Mueller, Celine; Heymans, Antonia et al.

Approach to risk stratification for papillary thyroid carcinoma based on molecular profiling: institutional analysis

BJS OPEN. Bd. 7. H. 3. 2023


Gerber, Tiemo Sven; Porubsky, Stefan

Benign lesions of the mediastinum

HISTOPATHOLOGY. 2023


Stenzel, Philipp Joachim; Schindeldecker, Mario; Seidmann, Larissa et al.

CD15 is a risk predictor and a novel target in clear cell renal cell carcinoma

PATHOBIOLOGY. 2023